Caribou Biosciences, Inc. (CRBU) Financials
CRBU Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 406.8 million | 63.5 million |
2023-12-31 | 441.0 million | 72.6 million |
2023-09-30 | 457.5 million | 59.3 million |
2023-06-30 | 349.6 million | 80.2 million |
CRBU Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -38.7 million | 4.0 million |
2023-12-31 | -23.7 million | 3.6 million |
2023-09-30 | -33.5 million | 3.5 million |
2023-06-30 | -17.7 million | 3.6 million |
CRBU Net Income
No data available :(
CRBU Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 294.0 million | - | 27.2 million |
2023-12-31 | 328.8 million | - | 27.1 million |
2023-09-30 | 338.5 million | - | 27.5 million |
2023-06-30 | 292.5 million | - | 27.2 million |
CRBU Shares Outstanding
CRBU Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 1.4 million | 33.8 million | 14.6 million | - |
2023-12-31 | 2.3 million | 31.3 million | 9.7 million | 2.0 million |
2023-09-30 | 4.8 million | 28.6 million | 9.7 million | - |
2023-06-30 | 2.6 million | 26.5 million | 10.1 million | - |
CRBU Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 2.4 million | 710000 |
2023-12-31 | 3.6 million | 2.0 million |
2023-09-30 | 23.7 million | 2.1 million |
2023-06-30 | 3.8 million | 1.1 million |
CRBU
Price: $2.85
52 week price:
Earnings Per Share: -1.38 USD
P/E Ratio: -4.81
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 355500
Market Capitalization: 319.7 million